Eagle Asset Management’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-352,860
| Closed | -$39.9M | – | 615 |
|
|
2021
Q1 | $39.9M | Buy |
352,860
+25,307
| +8% | +$2.86M | 0.18% | 181 |
|
|
2020
Q4 | $45.3M | Sell |
327,553
-23,268
| -7% | -$3.22M | 0.26% | 146 |
|
|
2020
Q3 | $29.9M | Buy |
350,821
+75,574
| +27% | +$6.43M | 0.15% | 191 |
|
|
2020
Q2 | $20.3M | Buy |
+275,247
| New | +$20.3M | 0.12% | 213 |
|
|
2017
Q4 | – | Sell |
-475,875
| Closed | -$27.3M | – | 648 |
|
|
2017
Q3 | $27.3M | Sell |
475,875
-4,904
| -1% | -$281K | 0.16% | 221 |
|
|
2017
Q2 | $29.9M | Buy |
480,779
+46,539
| +11% | +$2.89M | 0.18% | 194 |
|
|
2017
Q1 | $29.4M | Sell |
434,240
-1,476
| -0.3% | -$100K | 0.19% | 171 |
|
|
2016
Q4 | $30.6M | Buy |
435,716
+3,847
| +0.9% | +$270K | 0.2% | 153 |
|
|
2016
Q3 | $30.6M | Buy |
431,869
+89,329
| +26% | +$6.34M | 0.21% | 153 |
|
|
2016
Q2 | $16.8M | Sell |
342,540
-12,222
| -3% | -$598K | 0.12% | 243 |
|
|
2016
Q1 | $22.5M | Sell |
354,762
-7,754
| -2% | -$491K | 0.16% | 192 |
|
|
2015
Q4 | $40.7M | Buy |
362,516
+8,009
| +2% | +$898K | 0.27% | 128 |
|
|
2015
Q3 | $34.1M | Buy |
+354,507
| New | +$34.1M | 0.23% | 147 |
|